Search results
Results from the WOW.Com Content Network
Obese people tend to have raised levels of the hormone leptin, which is secreted by adipose tissue and under normal circumstances increases ventilation. In OHS, this effect is reduced. [5] [10] Furthermore, episodes of nighttime acidosis (e.g. due to sleep apnea) lead to compensation by the kidneys with retention of the alkali bicarbonate. This ...
780.50 Sleep disturbance, unspecified; 780.51 Insomnia with sleep apnea, unspecified; 780.52 Insomnia, unspecified; 780.53 Hypersomnia with sleep apnea, unspecified; 780.54 Hypersomnia, unspecified; 780.55 Disruption of 24 hour sleep wake cycle, unspecified; 780.56 Dysfunctions associated with sleep stages or arousal from sleep; 780.57 ...
Without treatment, the sleep deprivation and lack of oxygen caused by sleep apnea increases health risks such as cardiovascular disease, aortic disease (e.g. aortic aneurysm), [165] high blood pressure, [166] [167] stroke, [168] diabetes, clinical depression, [169] weight gain, obesity, [66] and even death.
Untreated sleep apnea can lead to serious health conditions. Moderate to severe sleep apnea can increase your risk of: High blood pressure. Heart failure. Cardiovascular disease. Stroke. Fatty ...
Sleep apnea is measured by the apnea-hypopnea index (AHI). An AHI is determined with a sleep study. AHI values for adults are categorized as: [2] [3] Normal: AHI<5; Mild sleep apnea: 5≤AHI<15; Moderate sleep apnea: 15≤AHI<30; Severe sleep apnea: AHI≥30; An episode is when a person hesitates to breathe or stops their breathing altogether.
Specialty: Otorhinolaryngology, sleep medicine: Symptoms: Pauses breathing or periods of shallow breathing during sleep, snoring, tired during the day [1] [2]: Complications: Heart attack, Cardiac arrest, stroke, diabetes, heart failure, irregular heartbeat, obesity, motor vehicle collisions, [1] Alzheimer's disease, [3] and premature death [4]
The regulator approved the drug for moderate to severe obstructive sleep apnea in adults with obesity, the company said. The approval opens up a wide market of patients for Lilly at a time when ...
This is a shortened version of the sixteenth chapter of the ICD-9: Symptoms, Signs and Ill-defined Conditions. It covers ICD codes 780 to 799. The full chapter can be found on pages 455 to 471 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1.